To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

THA: No difference between low-profile cup and Standard cup in terms of migration and wear

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites

THA: No difference between low-profile cup and Standard cup in terms of migration and wear

Vol: 2| Issue: 7| Number:181| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

No difference in migration or wear between cemented low-profile cups and standard cups : A randomized radiostereographic study of 53 patients over 3 years

Acta Orthop. 2007 Aug;78(4):479-84

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

60 patients with primary osteoarthritis awaiting total hip replacement, from ages 60-80 years, were randomized to either receive THR using a low-profile Lubinus Flanged Anti-Luxation Cup (FAL) or the Lubinus Standard Eccentric cup. The results at 3 years indicated that there no difference between the Lubinus FAL cup and the Lubinus Standard cup with respect to migration and wear.

Publication Funding Details +
Funding:
Industry funded
Sponsor:
Waldemar Link GmbH & Co
Conflicts:
None disclosed

Risk of Bias

5/10

Reporting Criteria

16/20

Fragility Index

N/A

Was the allocation sequence adequately generated?

Was allocation adequately concealed?

Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?

Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?

Blinding Patients: Was knowledge of the allocated interventions adequately prevented?

Was loss to follow-up (missing outcome data) infrequent?

Are reports of the study free of suggestion of selective outcome reporting?

Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?

Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?

Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?

Yes = 1

Uncertain = 0.5

Not Relevant = 0

No = 0

The Reporting Criteria Assessment evaluates the transparency with which authors report the methodological and trial characteristics of the trial within the publication. The assessment is divided into five categories which are presented below.

3/4

Randomization

2/4

Outcome Measurements

4/4

Inclusion / Exclusion

4/4

Therapy Description

3/4

Statistics

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

The Fragility Index is a tool that aids in the interpretation of significant findings, providing a measure of strength for a result. The Fragility Index represents the number of consecutive events that need to be added to a dichotomous outcome to make the finding no longer significant. A small number represents a weaker finding and a large number represents a stronger finding.

Why was this study needed now?

In total hip replacement procedures, a higher degree of containment within the bony acetabulum is achieved with low-profile acetabular components. Incidence of radioluency and wear may be reduced with the complete bony containment of cups. The low-profile design allows for greater range of free motion before femoral neck and cup impingement occurs. However, in contrast, the low-profile cups result in decreased containment of the prosthetic head within the cup therefore increasing the risk of instability or dislocation. It was reported that use of the SHP (low-profile) cup resulted in increased migration and wear, at the same time as the Lubinus Flanged Anti-Luxation Cup (FAL) was being introduced. This resulted in the need to compare this FAL low-profile cup to Standard cups, in order to examine the safety of the FAL cup and it's effects of migration and wear.

What was the principal research question?

How does the low-profile Lubinus Flanged Anti-Luxation Cup (FAL) compare to the Lubinous Standard Eccentric cup, in terms of the effects on migration and wear, in patients with primary osetoarthritis undergoing total hip replacement, measured at a 3 year follow up period?

Study Characteristics -
Population:
60 patients (aged 60-80 years) were included in the study. 7 patients were lost to follow up or did not meet inclusion criteria, and therefore 53 patients were available for analysis. These patients presented with primary osteoarthritis and were scheduled to undergo total hip replacement
Intervention:
FAL Group: Patients assigned to this group received THR using a low-profile Lubinus Flanged Anti-Luxation (FAL) cup (n=28 patients available for analysis; Median Age: 80 years; M/F=14/14).
Comparison:
Standard Group: Patients assigned to this group received THR using the Lubinus Standard Eccentric cup (n=25 patients available for analysis; Median Age: 69; M/F=14/11).
Outcomes:
Primary outcome measures included cup migration (maximal total point motion) and wear (total, three-dimensional vector of femoral head penetration), and were measured using radiostereometry (RSA) at 1 and 3 years. As well, clinical outcomes were measured using the WOMAC and VAS scores.
Methods:
RCT
Time:
Cup migration and wear were measured within one week post-op, 3, 6, 12 and 36 months post-operatively. Clinical outcomes measured pre-operatively and at 3, 6, and 12 months after surgery.

What were the important findings?

  • There was no difference in cup migration (MTPM values) between the two groups (p=0.7 at 1 year, p=0.8 at 3 years).
  • There was no difference between groups in terms of wear (p=0.9 at 1 year, p=0.7 at 3 years).
  • The clinical results (WOMAC, VAS rest, VAS activity) were excellent, with no significant differences between both groups (all p>0.05).
  • 3 cups (2 FAL, 1 Standard) reported increased proximal migration that indicated an increased risk of early loosening.
  • No correlation was observed between migration and wear.

What should I remember most?

There was no significant difference between The Lubinus FAL cup and the Lubinus Standard cup, in terms of migration and wear, measured at 1 and 3 years following surgery. Clinical outcomes were equally favorable in both groups.

How will this affect the care of my patients?

In patients where a low-profile cup is acceptable and suitable, this study indicates that the FAL cup is safe and effective for patients undergoing total hip replacement. Further high-quality evidence with larger sample sizes is needed to evaluate the safety and efficacy of this novel implant.

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue